Literature DB >> 67043

The G0-G1 transition of WI38 cells. I. Laser flow microfluorimetric studies.

C Nicolini, F Kendall, R Baserga, C Dessaive, B Clarkson, J Fried.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 67043     DOI: 10.1016/0014-4827(77)90247-6

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


× No keyword cloud information.
  7 in total

1.  Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

Authors:  L Walker; G Guy; G Brown; M Rowe; A E Milner; J Gordon
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

2.  The quinternary chromatin-DNA structure. Three-dimensional reconstruction and functional significance.

Authors:  F M Kendall; F Beltrame; S Zietz; A Belmont; C Nicolini
Journal:  Cell Biophys       Date:  1980-12

Review 3.  Normal versus abnormal cell proliferation. A unitary and analytical overview.

Authors:  C Nicolini
Journal:  Cell Biophys       Date:  1980-12

4.  Reversible (G0) and nonreadily reversible (Q) noncycling cells in human peripheral blood. Immunological, structural, and biological characterization.

Authors:  S Abraham; E Vonderheid; S Zietz; F M Kendall; C Nicolini
Journal:  Cell Biophys       Date:  1980-12

5.  Activated and cycling lymphocytes in benign dermal lymphocytic infiltrates including psoriatic skin lesions.

Authors:  G Lange Wantzin; J K Larsen; I J Christensen; E Ralfkiaer; M Tjalve; M Lund Kofoed; K Thomsen
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

6.  Fluorescent staining of intracellular and extracellular bacteria in blood.

Authors:  J D Mansour; J L Schram; T H Schulte
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

7.  Effect of cell density on binding and uptake of low density lipoprotein by human fibroblasts.

Authors:  H S Kruth; J Avigan; W Gamble; M Vaughan
Journal:  J Cell Biol       Date:  1979-12       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.